CER Daily Newsfeed

NPC's CER Daily Newsfeed® is your only daily source for the latest news and information on comparative effectiveness research.

Bookmark this webpage to check the postings each day, or sign up online to receive the updates via email. Questions or comments? Let us know!

Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

CER Tweets of the Week: #OHRP’s Informed Consent Guidelines, @AHRQNews On Real-World Primary Care Evaluation (November 10-14)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared the New England Journal of Medicine’s (@NEJM) paper on the concept...
Blog Post

CER Tweets of the Week: #ISPORAmst, PCORI and Health Affairs to Talk Patient Engagement (November 3-7)

What were comparative effectiveness research (CER) stakeholders tweeting about this week? We saw a lot of chatter about the International Society for...
Press Release

Eisai’s David Martin Elected as National Pharmaceutical Council’s Chairman of the Board

[[{"fid":"32030","view_mode":"teaser","fields":{"format":"teaser","field_file_image_alt_text[und][0][value]":"dave-martin","...
Press Release

Eisai’s David Martin Elected as National Pharmaceutical Council’s Chairman of the Board

[[{"fid":"32030","view_mode":"teaser","fields":{"format":"teaser","field_file_image_alt_text[und][0][value]":"dave-martin","...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

CER Tweets of the Week: #OHRP’s Informed Consent Guidelines, @AHRQNews On Real-World Primary Care Evaluation (November 10-14)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared the New England Journal of Medicine’s (@NEJM) paper on the concept...
Blog Post

CER Tweets of the Week: #ISPORAmst, PCORI and Health Affairs to Talk Patient Engagement (November 3-7)

What were comparative effectiveness research (CER) stakeholders tweeting about this week? We saw a lot of chatter about the International Society for...
Blog Post

CER Tweets of the Week (October 27-31): #mindqualitygap, PCORnet's First Pilot Trial

Health care stakeholders tweeted from the October 30 conference, “Mind the Gap: Improving Quality Measures in Accountable Care Systems,” co-sponsored...

Research

  •  
  • 1 of 16
  • >

Commentary & Testimony